Emily Dorman; David Bishai


Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(5):605-613. 

In This Article

Estimating Demand Based on Secondary Data Analysis

Data on the use of male contraceptives among key demographics offers an alternative perspective to quantifying the demand for novel male methods (Table 4). The National Survey for Family Growth indicates that 6% of American men have had a vasectomy (2006–2010 cycle) and 7.5% of married couples rely exclusively on condoms.[47] While not all men who choose vasectomy would substitute another male method were it available and not all married couples use condoms only for contraceptive purposes, these percentages suggest a potential consumer pool as large or larger than several current female methods. For instance, only 0.3% of all women between 15 and 49 years of age who are married or in a union currently use a hormonal implant for contraception, amounting to approximately 3.5 million users; approximately 41.3 million such women use injectables globally (Table 2).[48] Furthermore, 9% of never married American men have fathered a child,[103] which helps to approximate the number of men who may desire more control over their own fertility. The population of US men likely to be in sexual unions with fertile women (age 15–45 years) could be conservatively estimated from census 2010 at 75 million men (age 15–49 years) or more liberally at 110 million (age 15–69 years).